MMJ Group Holdings Ltd. engages in the commercialization of cannabis for medical purposes. It operates through the following segments: Cultivation, Processing and Distribution, Clinical Development, and Investment Entity.The Cultivation segment include the progression of applications for cultivation and distribution licenses. The Processing and Distribution segment includes the distribution of pharmaceutical, nutraceutical, and cosmetics product throughout the European market. The Clinical Development segment consists of clinical research of new and existing delivery systems and devices that have the potential to deliver safe, effective and measured doses of medical cannabis to patients. The Investment Entity segment measures and evaluates the performance of substantially all of its investments on a fair value basis. The company was founded by Ross Smith on August 14, 2014 and is headquartered in Sydney, Australia.